Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
12.16
-0.03 (-0.25%)
At close: Sep 19, 2024, 4:00 PM
12.76
+0.60 (4.93%)
After-hours: Sep 19, 2024, 5:51 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.25 billion as of September 19, 2024. Its market cap has increased by 27.40% in one year.
Market Cap
1.25B
Enterprise Value
1.10B
1-Year Change
27.40%
Ranking
Category
Stock Price
$12.16
Market Cap Chart
Since October 5, 2018, Immatics's market cap has increased from $127.10M to $1.25B, an increase of 886.44%. That is a compound annual growth rate of 46.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2024 | 1.26B | 41.00% |
| Dec 29, 2023 | 891.40M | 55.92% |
| Dec 30, 2022 | 571.70M | -32.38% |
| Dec 31, 2021 | 845.50M | 336.05% |
| Dec 31, 2020 | 193.90M | 3.75% |
| Dec 31, 2019 | 186.90M | 6.13% |
| Dec 31, 2018 | 176.10M | 38.55% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtriCure | 1.35B |
| Brookdale Senior Living | 1.34B |
| Avadel Pharmaceuticals | 1.32B |
| Integra LifeSciences Holdings | 1.32B |
| Maravai LifeSciences Holdings | 1.30B |
| Evotec SE | 1.28B |
| Gyre Therapeutics | 1.27B |
| Phathom Pharmaceuticals | 1.27B |